Genetics pioneer;
Born: December 30, 1930; Died: April 7, 2013.
AN APPRECIATION
Ken Murray was one of the most eminent scientists in the United Kingdom and an international leader of scientific innovation. He developed the first vaccine against viral hepatitis B, which has saved countless lives worldwide.
Prof Murray was one of the earliest workers in genetic engineering, which has opened a new avenue of scientific research and has led to new treatments for diseases and genetic disorders. He was co-founder of the first European based biotechnology company, Biogen. Most of his commercial income was used to found the Darwin Trust in 1983. The trust has supported the education of many young scientists, and helped fund cutting-edge research and improved facilities at the University of Edinburgh.
He was born in Yorkshire and brought up in the Midlands. He left school at the age of 16 to become a laboratory technician at Boots in Nottingham. After part-time study he obtained a first-class honours degree in chemistry and a PhD in microbiology from the University of Birmingham. It was in Birmingham that he met his wife, Noreen, who was to become a close scientific collaborator. They were married in 1958 and shared many interests, such as hill walking and camping.
He continued his research at Stanford University and returned to the UK in 1964 where he worked in the Medical Research Council Laboratory of Molecular Biology. He joined the University of Edinburgh in 1967 at what was then the only department of molecular biology in the country.
He and his colleagues made the university a leader in the molecular biology revolution. He was head of molecular biology from 1976 to 1984. Following his retirement in 1998, he continued to come to the laboratory every day, leading further scientific endeavours. Increasingly, he spent more time on his philanthropic support of others through the Darwin Trust.
He received much recognition for his outstanding work. He was elected to the Royal Society in 1979, received the Willem Meindart de Hoop Prize in 1983, and in 1992 was given a Saltire Society Scientific Award. He was knighted in 1993 and received a Royal Medal by the Royal Society of Edinburgh in 2000. In 2010, he and Noreen jointly received a lifetime achievement award from Nexus Life Sciences. Recently the Noreen and Kenneth Murray Library was built at the King's Buildings Science Campus at the University of Edinburgh, recognising their distinguished careers.
Despite the wealth from his vaccine and his various successes, he remained a modest and approachable person. His scientific interests lay in methods for sequencing, or deciphering, strands of DNA code. He developed methods based on new ideas, to isolate specific genes, and so began genetic engineering. Along with Noreen and others, he developed recombinant DNA technology, or gene cloning. This represented a revolution for scientists in terms of understanding how cells work, how genetics work and how the development of organisms is controlled and how it can go wrong.
He immediately put these ideas to a practical task – how to create a vaccine for a devastating liver disease, hepatitis B. He found a way to identify the hepatitis B virus and then produced a man-made vaccine. This was done under very difficult conditions, as people were scared of new genetic engineering technology, and so he had to work in secure facilities. By 1978, Ken and colleagues had created the vaccine and later proved it was effective in treating hepatitis. He was involved in the establishment of Biogen, which commercially developed the vaccine for use.
He had suffered from ill health for a number of years, yet remained active intellectually. He survived Noreen in 2011. Although they had no children, they leave behind a large community of colleagues and friends. This includes the students and colleagues with whom he shared his ideas willingly, colleagues who were able to use his techniques and materials for their own scientific research, those whose education he financed, and the many who did not know him but whose lives were improved because of his work. He will be sadly missed.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article